BIO
Bio-Rad Laboratories, Inc. (BIO) reported net income of $759.90M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $759.90M | +141.2% |
| FY 2024 | -$1.84B | -189.4% |
| FY 2023 | -$637.30M | +82.4% |
| FY 2022 | -$3.63B | -185.3% |
| FY 2021 | $4.25B | +11.5% |
| FY 2020 | $3.81B | +116.9% |
| FY 2019 | $1.76B | +381.0% |
| FY 2018 | $365.61M | +199.1% |
| FY 2017 |
Bio-Rad Laboratories, Inc. (BIO) reported net income of $759.90M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, Bio-Rad Laboratories, Inc.'s net income grew from $179.01M to $759.90M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $122.25M |
| +370.2% |
| FY 2016 | $26.00M | -76.2% |
| FY 2015 | $109.24M | +23.0% |
| FY 2014 | $88.84M | +14.2% |
| FY 2013 | $77.79M | -53.0% |
| FY 2012 | $165.48M | -7.6% |
| FY 2011 | $179.01M | - |